Effects of an autoinducer analogue on antibiotic tolerance in Pseudomonas aeruginosa

The Journal of Antimicrobial Chemotherapy
Takashi AmohYoichiro Miyake

Abstract

Antibiotic tolerance causes chronic, refractory and persistent infections. In order to advance the development of a new type of drug for the treatment of infectious diseases, we herein investigated the effects of a newly synthesized analogue of the Pseudomonas aeruginosa quorum-sensing autoinducer named AIA-1 ( a uto i nducer a nalogue) on antibiotic tolerance in P. aeruginosa . A P. aeruginosa luminescent strain derived from PAO1 was injected into neutropenic ICR mice and bioluminescence images were acquired for a period of time after treatments with antibiotics and AIA-1. In vitro susceptibility testing and killing assays for the planktonic and biofilm cells of PAO1 were performed using antibiotics and AIA-1. The expression of quorum-sensing-related genes was examined using real-time PCR. In vivo and in vitro assays showed that AIA-1 alone did not exert any bactericidal effects and also did not affect the MICs of antibiotics. However, the combined use of AIA-1 and antibiotics exerted markedly stronger therapeutic effects against experimental infection than antibiotics alone. The presence of AIA-1 also enhanced the killing effects of antibiotics in planktonic and biofilm cells. Although AIA-1 did not inhibit the expression of ...Continue Reading

References

Jan 1, 1985·Annual Review of Pharmacology and Toxicology·S Handwerger, A Tomasz
Jul 14, 2000·Journal of Bacteriology·M WhiteleyE P Greenberg
Oct 6, 2000·Annual Review of Microbiology·A Ishihama
Mar 20, 2003·Journal of Bacteriology·Victoria E WagnerBarbara H Iglewski
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Kazuko TaniguchiYoichiro Miyake
Sep 6, 2003·Journal of Clinical Microbiology·Joslyn ConleyH Dele Davies
Oct 29, 2003·Current Opinion in Chemical Biology·Hiroaki Suga, Kristina M Smith
Feb 7, 2004·Molecular Microbiology·Martin SchusterE P Greenberg
May 27, 2004·Investigative Ophthalmology & Visual Science·Hua ZhuMark D P Willcox
Dec 29, 2004·FEMS Microbiology Letters·Keiji MurakamiYoichiro Miyake
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Christopher M Waters, Bonnie L Bassler
Feb 16, 2006·International Journal of Medical Microbiology : IJMM·Martin Schuster, E Peter Greenberg
Jan 31, 2007·Antimicrobial Agents and Chemotherapy·Darija ViducicYoichiro Miyake
Aug 4, 2009·FEMS Microbiology Letters·Shizuo KayamaYoichiro Miyake
May 26, 2010·FEMS Immunology and Medical Microbiology·Morten HarmsenTim Tolker-Nielsen
Mar 23, 2011·Antimicrobial Agents and Chemotherapy·Gilles BrackmanTom Coenye
Oct 23, 2012·Methods in Enzymology·Iris KerenKim Lewis
Sep 25, 2014·Protein & Cell·Jasmine Lee, Lianhui Zhang
Apr 15, 2015·Antimicrobial Agents and Chemotherapy·Philip S StewartGarth A James
Jul 20, 2016·Antimicrobial Agents and Chemotherapy·Darija ViducicYoichiro Miyake

❮ Previous
Next ❯

Citations

Sep 23, 2020·PloS One·Y A NikolaevG I El'-Registan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.